AbbVie's R&D expenditures as revenue share 2012-2023
This statistic illustrates the expenditure of AbbVie on research and development as a percentage of revenue from 2012 to 2023. In 2023, AbbVie spent some 14 percent of its revenue on research and development, which is a low percentage for a leading pharmaceutical company. Abbot was a U.S.-based global pharmaceutical and healthcare products company, headquartered in Chicago, Illinois. In January 2013, Abbott was separated into two companies: Abbott Laboratories and AbbVie. Abbott Laboratories is now specialized on medical products, while AbbVie is responsible for research-based pharmaceuticals. On May 8, 2020, AbbVie completed the acquisition of Allergan plc.